Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 71Thoracic 31Genitourinary 29Gynecologic 24Breast 23Other hematologic neoplasm 21Lymphoid 21Head & Neck 18CNS 14Dermatologic 10Sarcoma 9Tumor-Agnostic 7Plasma cell 7Myeloid 6Endocrine 6Other 4Classical hematology 4Other solid neoplasm 3Other neoplasm 2

Conditions

Venous Thromboembolism 2Thrombosis 1Thrombophilia 1Thrombocytopenia 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukopenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Hypersplenism 1Hemoglobinuria, Paroxysmal 1Hematologic Neoplasms 1Hematologic Diseases 1Antiphospholipid Syndrome 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observation × Classical hematology × Clear all
NCT07108023 2025-08-06

EHPVO-HEM

Assiut University

Not yet recruiting
115 enrolled
Classical hematologyMyeloid

Anemia, Hematologic Diseases, Hemoglobinuria, Paroxysmal, Hypersplenism, Leukopenia, Myeloproliferative Disorders, Thrombocytopenia, Antiphospholipid Syndrome, Thrombophilia

NCT00093470 2024-03-20

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

National Cancer Institute (NCI)

Phase 3 Completed
144 enrolled 8 charts
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
17 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

NCT01855698 2018-03-22

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed
99 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡